191
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis

, , , , , , , , , , , , & show all
Pages 185-192 | Received 02 Oct 2010, Accepted 10 Dec 2010, Published online: 04 Jan 2011

References

  • Pettersson S. Introduction: Inflammatory bowel disease: a complex systemic disease engaging multiple players outside the immune system. J Intern Med 2008;263:574–6.
  • Kucharzik T, Maaser C, Lügering A, Kagnoff M, Mayer L, Targan S, Domschke W. Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis 2006;12:1068–83.
  • Gorgulu S, Yagci G, Kaymakcioglu N, Ozkara M, Kurt B, Ozcan A, Kaya O, Sadir S, Tufan T. Hyperbaric oxygen enhances the efficiency of 5-aminosalicylic acid in acetic acid-induced colitis in rats. Dig Dis Sci 2006;51:480–7.
  • Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM 2004;97:385–95.
  • Rachmilewitz D, Karmeli F, Okon E, Rubenstein I, Better OS. Hyperbaric oxygen: a novel modality to ameliorate experimental colitis. Gut 1998;43:512–8.
  • Gulec B, Yasar M, Yildiz S, Oter S, Akay C, Deveci S, Sen D. Effect of hyperbaric oxygen on experimental acute distal colitis. Physiol Res 2004;53:493–9.
  • Ercin CN, Yesilova Z, Korkmaz A, Ozcan A, Oktenli C, Uygun A. The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis. Dig Dis Sci 2009;54:75–9.
  • Bocci V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediators Inflamm 2004;13:3–11.
  • Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res 2006;37:425–35.
  • Oter S, Korkmaz A. Relevance of hyperbaric oxygen to ozone therapy. Arch Med Res 2006;37:917–8.
  • Bocci V. Does ozone therapy normalize the cellular redox balance? Implications for therapy of human immunodeficiency virus infection and several other diseases. Med Hypotheses 1996;46:150–4.
  • Re L, Mawsouf MN, Menéndez S, León OS, Sánchez GM, Hernández F. Ozone therapy: clinical and basic evidence of its therapeutic potential. Arch Med Res 2008;9:17–26.
  • Huber C, Fuchs D, Hausen A, Margreiter R, Reibnegger G, Spielberger M, Wachter H. Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants. J Immunol 1983;130:1047–50.
  • Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 2001;26:319–29.
  • Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol 1993;101:1–6.
  • Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985;135:3172–7.
  • Poulakis N, Sarandakou A, Rizos D, Phocas I, Kontozoglou T, Polyzogopoulos D. Soluble interleukin-2 receptors and other markers in primary lung cancer. Cancer 1991;68:1045–9.
  • Bianchi A, Mariani S, Beggiato E, Borrione P, Peola S, Boccadoro M, Pileri A, Massaia M. Distribution of T-cell signaling molecules in human myeloma. Br J Haematol 1997;97:815–20.
  • Sharon P, Stenson WP. Metabolism of arachidonic acid in acetic colitis in rats: similarity to human inflammatory bowel disease. Gastroenterology 1995;88:55–63.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75.
  • Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–8.
  • Durak I, Yurtarslanl Z, Canbolat O, Akyol O. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin Chim Acta 1993;214:103–4.
  • Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158–69.
  • Alrashed M, Abougoush M, Akgul EO, Erbil MK, Boyunaga H, Almarafi A, Akman S, Kutluay T. Detection method of serum and urine neopterin levels by high performance liquid chromatography and clinical applications. Gulhane MJ 2002;44:273–7 [in Turkish].
  • Ruokonen E, Ilkka L, Niskanen M, Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 2002;46:398–404.
  • Muller MM, Curtius HC, Herold M, Huber CH. Neopterin in clinical practice. Clin Chim Acta 1991;201:1–16.
  • Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H. Immune response associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984;160:310–6.
  • Turgan N, Habif S, Parildar Z, Ozmen D, Mutaf I, Erdener D, Bayindir O. Association between homocysteine and neopterin in healthy subjects measured by a simple HPLC-fluorometric method. Clin Biochem 2001;34:271–5.
  • Nancey S, Perret-Liaudet A, Moussata D, Graber I, Boschetti G, Renaud B, Kaiserlian D, Reimund JM, Flourié B. Urinary neopterin is a valuable tool in monitoring Crohn's disease activity. Inflamm Bowel Dis 2008;14:1548–54.
  • Forrest CM, Youd P, Kennedy A, Gould SR, Darlington LG, Stone TW. Purine, kynurenine, neopterin and lipid peroxidation levels in inflammatory bowel disease. J Biomed Sci 2002;9:436–42.
  • Niederwieser D, Fuchs D, Hausen A, Judmaier G, Reibnegger G, Wachter H, Huber C. Neopterin as a new biochemical marker in the clinical assessment of ulcerative colitis. Immunobiology 1985;170:320–6.
  • Narkowicz CK, Vial JH, McCartney PW. Hyperbaric oxygen therapy increases free radical levels in the blood of humans. Free Radic Res Commun 1993;19:71–80.
  • Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997;22:269–85.
  • Hink J, Jansen E. Are superoxide and/or hydrogen peroxide responsible for some of the beneficial effects of hyperbaric oxygen therapy? Med Hypotheses 2001;57:764–9.
  • Buras J. Basic mechanisms of hyperbaric oxygen in the treatment of ischemia-reperfusion injury. Int Anesthesiol Clin 2000;38:91–109.
  • Korkmaz A, Oter S, Deveci S, Ozgurtas T, Topal T, Sadir S, Bilgic H. Involvement of nitric oxide and hyperbaric oxygen in the pathogenesis of cyclophosphamide induced hemorrhagic cystitis in rats. J Urol 2003;170:2498–502.
  • Oter S, Edremitlioglu M, Korkmaz A, Coskun O, Kilic D, Kisa U, Yaren H, Bilgic H. Effects of hyperbaric oxygen treatment on liver functions, oxidative status and histology in septic rats. Intensive Care Med 2005;31:1262–8.
  • Yilmaz MI, Korkmaz A, Kaya A, Sonmez A, Caglar K, Topal T, Eyileten T, Yenicesu M, Acikel C, Oter S, Yaman H, Aktug H, Oguz Y, Vural A, Ikizler TA. Hyperbaric oxygen treatment augments the efficacy of a losartan regime in an experimental nephrotic syndrome model. Nephron Exp Nephrol 2006;104:e15–22.
  • Hamzaoğlu I, Karahasanoğlu T, Aydin S, Sahin DA, Carkman S, Sariyar M, Alemdaroğlu K. The effects of hyperbaric oxygen therapy on normal and ischemic colon anastomoses. Am J Surg 1998;176:458–61.
  • Lavy A, Weisz G, Adir Y, Ramon Y, Melamed Y, Eidelman S. Hyperbaric oxygen for perianal Crohn's disease. J Clin Gastroenterol 1994;19:202–5.
  • Atug O, Hamzaoglu H, Tahan V, Alican I, Kurtkaya O, Elbuken E, Ozdogan O, Tozun N. Hyperbaric oxygen therapy is as effective as dexamethasone in the treatment of TNBS-E-induced experimental colitis. Dig Dis Sci 2008;53:481–5.
  • Quirinia A, Viidik A. The effect of hyperbaric oxygen on different phases of healing of ischaemic flap wounds and incisional wounds in skin. Br J Plast Surg 1995;48:583–9.
  • Bocci V, Aldinucci C. Biochemical modifications induced in human blood by oxygenation-ozonation. J Biochem Mol Toxicol 2006;20:133–8.
  • Halliwell B, Clement MV, Long LH. Hydrogen peroxide in the human body. FEBS Lett 2000;486:10–3.
  • Zamora ZB, Borrego A, López OY, Delgado R, González R, Menéndez S, Hernández F, Schulz S. Effects of ozone oxidative preconditioning on TNF-alpha release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock. Mediators Inflamm 2005;2005:16–22.
  • Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 2002;3:1129–34.
  • Ajamieh H, Merino N, Candelario-Jalil E, Menéndez S, Martinez-Sanchez G, Re L, Giuliani A, Leon OS. Similar protective effect of ischaemic and ozone oxidative preconditionings in liver ischaemia/reperfusion injury. Pharmacol Res 2002;45:333–9.
  • Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chen Z. Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Arch Med Res 2008;39:169–78.
  • Madej P, Plewka A, Madej JA, Nowak M, Plewka D, Franik G, Golka D. Ozonotherapy in an induced septic shock. I. Effect of ozonotherapy on rat organs in evaluation of free radical reactions and selected enzymatic systems. Inflammation 2007;30:52–8.
  • Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chen Z. Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury. Eur J Pharmacol 2008;581:306–14.
  • Bocci VA. Why orthodox medicine has not yet taken advantage of ozone therapy. Arch Med Res 2008;39:259–60.
  • Eliakim R, Karmeli F, Rachmilewitz D, Cohen P, Zimran A. Ozone enema: a model of microscopic colitis in rats. Dig Dis Sci 2001;46:2515–20.
  • Guven A, Gundogdu G, Sadir S, Topal T, Erdogan E, Korkmaz A, Surer I, Ozturk H. The efficacy of ozone therapy in experimental caustic esophageal burn. J Pediatr Surg 2008;43:1679–84.
  • Guven A, Gundogdu G, Vurucu S, Uysal B, Oztas E, Ozturk H, Korkmaz A. Medical ozone therapy reduces oxidative stress and intestinal damage in an experimental model of necrotizing enterocolitis in neonatal rats. J Pediatr Surg 2009;44:1730–5.
  • Uysal B, Yasar M, Ersoz N, Coskun O, Kilic A, Cayc T, Kurt B, Oter S, Korkmaz A, Guven A. Efficacy of hyperbaric oxygen therapy and medical ozone therapy in experimental acute necrotizing pancreatitis. Pancreas 2010;39:9–15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.